CMG Pharmaceutical Co. Ltd - Asset Resilience Ratio

Latest as of December 2025: 6.66%

CMG Pharmaceutical Co. Ltd (058820) has an Asset Resilience Ratio of 6.66% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of CMG Pharmaceutical Co. Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩20.38 Billion

≈ $13.81 Million USD Cash + Short-term Investments

Total Assets

₩305.96 Billion

≈ $207.35 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how CMG Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. See 058820 net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down CMG Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 058820 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩20.38 Billion	6.66%
Total Liquid Assets	₩20.38 Billion	6.66%

Asset Resilience Insights

Limited Liquidity: CMG Pharmaceutical Co. Ltd maintains only 6.66% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CMG Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare CMG Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for CMG Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual Asset Resilience Ratio data for CMG Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.66%	₩20.38 Billion ≈ $13.81 Million	₩305.96 Billion ≈ $207.35 Million	-17.79pp
2024-12-31	24.46%	₩74.21 Billion ≈ $50.29 Million	₩303.44 Billion ≈ $205.63 Million	-3.46pp
2023-12-31	27.92%	₩67.58 Billion ≈ $45.80 Million	₩242.10 Billion ≈ $164.07 Million	-6.48pp
2022-12-31	34.40%	₩73.36 Billion ≈ $49.71 Million	₩213.26 Billion ≈ $144.52 Million	-10.96pp
2021-12-31	45.36%	₩90.34 Billion ≈ $61.22 Million	₩199.17 Billion ≈ $134.98 Million	-10.84pp
2020-12-31	56.19%	₩109.78 Billion ≈ $74.39 Million	₩195.36 Billion ≈ $132.39 Million	-6.01pp
2019-12-31	62.20%	₩119.57 Billion ≈ $81.03 Million	₩192.24 Billion ≈ $130.28 Million	+14.58pp
2018-12-31	47.62%	₩54.46 Billion ≈ $36.91 Million	₩114.38 Billion ≈ $77.51 Million	-4.22pp
2017-12-31	51.84%	₩56.80 Billion ≈ $38.49 Million	₩109.57 Billion ≈ $74.25 Million	-1.47pp
2016-12-31	53.31%	₩59.16 Billion ≈ $40.09 Million	₩110.98 Billion ≈ $75.21 Million	+44.46pp
2015-12-31	8.84%	₩5.00 Billion ≈ $3.39 Million	₩56.53 Billion ≈ $38.31 Million	+8.37pp
2014-12-31	0.48%	₩278.19 Million ≈ $188.53K	₩58.07 Billion ≈ $39.35 Million	-0.02pp
2013-12-31	0.50%	₩278.19 Million ≈ $188.53K	₩55.91 Billion ≈ $37.89 Million	-52.64pp
2012-12-31	53.14%	₩30.35 Billion ≈ $20.57 Million	₩57.11 Billion ≈ $38.70 Million	+49.22pp
2011-12-31	3.92%	₩1.07 Billion ≈ $726.07K	₩27.31 Billion ≈ $18.50 Million	--

pp = percentage points

About CMG Pharmaceutical Co. Ltd

KQ:058820 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$107.20 Million

₩158.19 Billion KRW

Market Cap Rank

#19015 Global

#909 in Korea

Share Price

₩1070.00

Change (1 day)

-6.06%

52-Week Range

₩1045.00 - ₩2140.00

All Time High

₩8318.64